TABLE 1.
Study population metrics.
| Total | Sex | Age (years) | BMI (kg/m2) | SAPS II score | |||||
|---|---|---|---|---|---|---|---|---|---|
| Female | Male | ||||||||
| Intensive care unit | COVID-19 | n | 12 | 6 | 6 | mean | 63.5 | 28.7 | 42.1 |
| % | 50 | 50 | SD | 9.1 | 6.4 | 12.0 | |||
| Cardiogenic Shock (CS) | n | 20 | 4 | 16 | mean | 69.1 | 25.7 | 48.7 | |
| % | 20 | 80 | SD | 16.0 | 3.1 | 13.8 | |||
| COVID-19 vs. CS | p-value | 0.277 | 0.088 | 0.182 | |||||
| Total | Sex | Age (years) | BMI (kg//m2) | Anti-S1 IgG titer | |||||
|---|---|---|---|---|---|---|---|---|---|
| Female | Male | ||||||||
| Non-hospitalized | Healthy Control (HC) | n | 58 a | 26 | 30 | mean | 51.0 | 25.2 | — |
| % | 46.4 | 53.6 | SD | 15.8 | 4.6 | — | |||
| Anti-S1-IgG+ | N | 18 | 8 | 10 | mean | 44.1 | 26.7 | 2.44 | |
| % | 44.4 | 55.6 | SD | 15.9 | 5.2 | 1.70 | |||
| Anti-S1-IgG- | N | 18 | 8 | 10 | mean | 44.1 | 25.2 | — | |
| % | 44.4 | 55.6 | SD | 15.9 | 4.1 | — | |||
| COVID-19 vs. HC | p-value | 0.010 | 0.030 | — | |||||
| Anti-S1-IgG+ vs. Anti-S1-IgG- | p-value | >0.999 | 0.342 | — | |||||
a
Two subjects unknown.